Synthesis of an oligonucleotide-derivatized amphipol and its use to trap and immobilize membrane proteins by Bon, Christel Le et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Synthesis of an oligonucleotide-derivatized amphipol and its use to trap and
immobilize membrane proteins
Bon, Christel Le; Della Pia, Eduardo Antonio; Giusti, Fabrice; Lloret, Noemie Denise Carmen;
Zoonens, Manuela; Martinez, Karen Laurence; Popot, Jean Luc
Published in:
Nucleic Acids Research
DOI:
10.1093/nar/gku250
Publication date:
2014
Document version
Publisher's PDF, also known as Version of record
Citation for published version (APA):
Bon, C. L., Della Pia, E. A., Giusti, F., Lloret, N. D. C., Zoonens, M., Martinez, K. L., & Popot, J. L. (2014).
Synthesis of an oligonucleotide-derivatized amphipol and its use to trap and immobilize membrane proteins.
Nucleic Acids Research, 42(10), [e83]. https://doi.org/10.1093/nar/gku250
Download date: 03. Feb. 2020
Published online 17 April 2014 Nucleic Acids Research, 2014, Vol. 42, No. 10 e83
doi: 10.1093/nar/gku250
Synthesis of an oligonucleotide-derivatized amphipol
and its use to trap and immobilize membrane proteins
Christel Le Bon1, Eduardo Antonio Della Pia2, Fabrice Giusti1, Noe´mie Lloret2,
Manuela Zoonens1, Karen L. Martinez2 and Jean-Luc Popot1,*
1UMR 7099, Centre National de la Recherche Scientifique/Universite´ Paris-7, Institut de Biologie Physico-Chimique
(FRC 550), 13 rue Pierre et Marie Curie, F-75005 Paris, France and 2Bio-Nanotechnology and Nanomedicine
Laboratory, Department of Chemistry and Nano-Science Center, University of Copenhagen, Universitetsparken 5,
DK-2100 Copenhagen, Denmark
Received January 9, 2014; Revised February 25, 2014; Accepted March 13, 2014
ABSTRACT
Amphipols (APols) are specially designed amphi-
pathic polymers that stabilize membrane proteins
(MPs) in aqueous solutions in the absence of de-
tergent. A8–35, a polyacrylate-based APol, has been
grafted with an oligodeoxynucleotide (ODN). The
synthesis, purification and properties of the result-
ing ‘OligAPol’ have been investigated. Grafting was
performed by reacting an ODN carrying an amine-
terminated arm with the carboxylates of A8–35. The
use of OligAPol for trapping MPs and immobilizing
them onto solid supports was tested using bacteri-
orhodopsin (BR) and the transmembrane domain of
Escherichia coli outer membrane protein A (tOmpA)
as model proteins. BR and OligAPol form water-
soluble complexes in which BR remains in its native
conformation. Hybridization of the ODN arm with a
complementary ODN was not hindered by the assem-
bly of OligAPol into particles, nor by its association
with BR. BR/OligAPol and tOmpA/OligAPol com-
plexes could be immobilized onto either magnetic
beads or gold nanoparticles grafted with the com-
plementary ODN, as shown by spectroscopic mea-
surements, fluorescence microscopy and the bind-
ing of anti-BR and anti-tOmpA antibodies. OligAPols
provide a novel, highly versatile approach to tagging
MPs, without modifying them chemically nor geneti-
cally, for specific, reversible and targetable immobi-
lization, e.g. for nanoscale applications.
INTRODUCTION
Amphipols (APols) are amphiphilic polymers that, when
substituted to detergents, stabilize membrane proteins
(MPs) in aqueous solutions (1,2). Their rich chemistry lends
itself to a large variety of applications, among which is the
indirect functionalization of the MPs they bind to (3–5).
The most thoroughly studied APol to date, A8–35 (6), com-
prises a short polyacrylate backbone [∼35 acrylate residues;
see (7)] randomly grafted with octylamine and isopropy-
lamine side chains (Inset of Scheme 1). The average molec-
ular mass of A8–35, which varies slightly depending on
that of the polyacrylate used for the synthesis, is ∼4.3 kDa
(7). In aqueous solutions, A8–35 self-organizes (8,9) into
small, globular, well-defined particles, whose average mass
is ∼40 kDa (10), and which, therefore, comprise on aver-
age ∼9–10 molecules. When an MP in detergent solution
is supplemented with APols and the detergent removed,
water-solubleMP/APol complexes form, in which the APol
specifically adsorbs onto the hydrophobic transmembrane
surface of the protein [reviewed in (2)]. Although it is non-
covalent, the association of APols with MPs, because it in-
volves multiple hydrophobic contact points, is essentially
irreversible even under conditions of extreme dilution, un-
less APols are displaced by an excess of another surfactant
(3,11,12). Complexation of an MP with a functionalized
APolwill therefore result in a stable functionalized complex.
In the present work, this property has been exploited to de-
velop a general approach to immobilizing MPs onto solid
supports via an oligodeoxynucleotide (ODN)-tagged APol.
The chemistry of APols offers a wide range of resources,
which permit to tailor them to specific biophysical or bio-
chemical applications [reviewed in (5)]. Thus, A8–35 has
been deuterated (13) and perdeuterated (7) in view of ap-
plications in nuclear magnetic resonance (NMR) [reviewed
in (14)], small angle neutron scattering or analytical ultra-
centrifugation [see, e.g. (15)]. APols labeled with various flu-
orophores (FAPols) have been used for studying the kinetics
of exchange of A8–35 at the surface of MPs (3) and its crit-
ical association constant (9).
Tagged APols can be used for trapping and immobiliz-
ing MPs onto solid supports. This application was first
demonstrated using biotinylated A8–35 (BAPol). Various
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Scheme 1. Reaction scheme for OligAPol synthesis. The formation of an activated carboxylate moiety by reaction with EDC and NHS is followed by
grafting of the amine-functionalized oligonucleotide (ODN) to form an amide bond. Inset: chemical structure of A8–35 [x ≈ 35%, y ≈ 25%, z ≈ 40%;
from (6)] and sequence of ODN CpG-1826.
MP/BAPol complexes were immobilized onto streptavidin-
coated beads or chips, and the interaction of antibodies and
pharmacological ligands with the proteins evidenced by ei-
ther surface plasmon resonance or fluorescence microscopy
(4,16,17). Four of the many advantages of using tagged
APols to indirectly tag MPs are (i) that any MP can be im-
mobilized, using a single tagged APol, without having un-
dergone any genetic or chemical modification, (ii) that trap-
ping in most cases stabilizes biochemically the protein, (iii)
that ligand binding can be measured in aqueous, detergent-
free solutions and (iv) that a large variety of tags can in
principle be used without having to develop often complex
or hazardous ways to attach them covalently to the target
MPs. Key features include the specificity of the attachment
to the support, its stability and its reversibility, the latter
being particularly important when working with costly sup-
ports that have to be regenerated. Because biotin-mediated
anchoring is essentially irreversible, exploring alternative at-
tachment modes is desirable.
We examine here the possibility of functionalizing A8–
35 with ODNs. The reversible immobilization of MPs via
an ODN tag presents major assets for the regeneration
and reconfiguration of biosensors and biochip surfaces. In
addition, ODNs offer rich possibilities of modulating the
stability and specificity of the attachment, by playing on
their length and sequence, and they lend themselves well
to multiplexing. They provide a chemically mild method
for the site-selective immobilization of multiple MPs onto
solid supports: traditional, well-established deoxyribonu-
cleic acid (DNA)microarrays could be easily adapted as im-
mobilization platforms. Previous studies have demonstrated
sequence-specific and site-selective immobilization of semi-
synthetic protein–ODN conjugates onto surfaces modified
with complementary nucleotide sequences (18,19). How-
ever, these methods require protein engineering or chemical
modification and cannot be easily adapted to MPs, which
tend to be fragile and hard to handle. An alternative strat-
egy is to first reconstitute the target MP in liposomes con-
taining a cholesterol-modified ODN and then bind the pro-
teoliposomes onto surfaces modified with the complemen-
tary ODN (cODN) (20). Reconstitution of MPs, however,
is a delicate, protein-specific process, and its optimization is
time-consuming.
In this article, we first describe a route for synthesizing
and purifying ODN-grafted A8–35. The ability of the re-
sulting ‘OligAPol’ to trap and anchor MPs onto surfaces
carrying the cODN is demonstrated using two different
types of solid supports, magnetic beads and gold nanoparti-
cles (AuNPs). In both cases, adsorption is specificallymedi-
ated by formation of the DNA duplex. Magnetic beads give
access to adsorption yields, AuNPs to the homogeneity and
reversibility of the adsorption.
MATERIALS AND METHODS
Materials
APol A8–35 was synthesized and characterized according
to the procedure described in (10,13), FAPolNBD according
to that described in (3). ODNs were purchased from Trilink
or AlphaDNA. Their characteristics are listed in Table 1. 1-
Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochlo-
ride (EDC) was from Alpha Aesar, N-hydroxysuccinimide
(NHS) and sodium cyanoborohydride (NaCNBH3) from
Sigma Chemicals, Bio-Beads SM-2 from Biorad and
n-octyl-β-D-thioglucopyranoside (OTG) from Anatrace.
Aldehyde-activated magnetic beads (1-m diameter) were
from Bioclone. The succinimidyl ester of Alexa Fluor 647
was from Invitrogen. Perdeuterated NMR solvents were
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fromVWR. Glass cover-slips (25-mm diameter, 0.17± 0.01
mm thick) were purchased fromHounisens Laboratorieud-
styr, 100-nm Au NPs and poly-l-lysine (PLL) from Sigma
and 2-[methoxy(polyethyleneoxy)propyl]trimethoxysilane,
tech-90 (PEG silane) from Gelest.
Buffers
Phosphate buffer: 100-mM NaCl, 20-mM sodium phos-
phate, pH 7.0. Standard chromatography buffer: 100-mM
NaCl, 20-mMTris/HCl, pH8.0. For experimentswithmag-
netic beads, coupling buffer was 100-mM sodium phos-
phate, pH 7.0; washing buffer: 1-M NaCl; hybridization
buffer: 300-mM NaCl, 30-mM sodium citrate, pH 7.4. For
immobilization on Au NPs, TE buffer was 10-mM Tris, pH
8.0, 1-mM ethylenediaminetetraacetic acid (EDTA); PPB
was 10-mM potassium phosphate buffer, pH 7.2; PPB-T20
was PPB + 0.001% Tween 20.
Methods
OligAPol synthesis and purification. Stock solutions of
A8–35 and ODN prepared in 0.4-M NaCl were stored at
4◦C; NHS and EDC were dissolved extemporaneously in
0.1-M phosphate buffer, pH 6.8. 3 ml of a 20.7-g/l A8–35
solution (∼14.4 mol polymer or∼176-mol free carboxy-
late functions) and 1.5 ml of a 15-g/l ODN solution (∼3.4
mol) were supplemented with 0.2 ml of a 600-g/l EDC
and 114-g/l NHS solution (molar ratios 4:1 and 1:1, re-
spectively, with respect to free carboxylate functions). The
solution was kept under stirring for 48 h and the reaction
monitored by fast protein (or fast performance) liquid chro-
matography (FPLC; see below) with the injection of 25-l
aliquots diluted to 300 l with chromatography buffer. The
reaction medium (∼4.5 ml) was diluted in 50-ml phosphate
buffer, pH 3.25, inducing precipitation of the polymer. The
pellet was recovered after a 5000-rpm centrifugation at 4◦C
during 15 min and resolubilized in 4.5 ml of phosphate
buffer, pH 8. The cycle of precipitation/solubilization was
repeated twice and followed by preparative size exclusion
chromatography (SEC) on the FPLC system. The collected
fractions were concentrated under 2 atm in a stirred Milli-
pore Alphacell with 10-kDa porosity to reduce the volume
to 50 ml. The solution was filtered through a 0.2-m sy-
ringe filter, dialyzed against water purified on a A10 Advan-
tageMillipore System (mQwater) using a Spectra/Por dial-
ysis membrane (cut off 6–8 kDa) for at least 2 h, and finally
freeze-dried, yielding 50mg of purifiedOligAPol (yield rela-
tive to A8–35:∼60%). [The yield of grafting never exceeded
one ODN per two particles. Repulsive interactions between
the two negatively charged partners (ODN and A8–35), as
well as the limited solubility of intermediates, may limit the
extent of derivatization. Reacting EDCwith carboxylates to
form first an O-acylurea intermediate, which evolves into
an amine-reactive NHS ester in the presence of NHS, re-
duces the number of free carboxylates that confer to A8-
35 its high solubility (10,13). Some of these groups subse-
quently become grafted with the highly hydrophilic ODN,
but themajority of them do not, leading to a global increase
of hydrophobicity until the ester is hydrolyzed to regenerate
the carboxylate. Since the balance of hydrophilic and hy-
drophobic groups in A8–35 is delicately poised (10,13), this
can lead to aggregation.]
FAPolAF647 synthesis. The detailed synthesis protocol of
the fluorescent APol FAPolAF647 is described elsewhere (21).
Briefly, it consists in reacting the amine moiety of the ‘uni-
versal’ APol [A8–35 grafted with a spacer arm carrying an
amine function; (3)] with the succinimidyl ester function of
a functionalized Alexa Fluor 647 dye. The grafting ratio is
∼3 fluorophores per 1000 PAA units. Each FAPolAF647 par-
ticle, which comprises ∼325 units, carries therefore ca. one
fluorophore. FAPolAF647 presents an absorption maximum
at 651 nm and an emission maximum at 668 nm (21).
Size exclusion chromatography. SEC was performed at
room temperature (RT) on an A¨kta Purifier 10 FPLC sys-
tem (GE Healthcare). Detection was performed at three
wavelengths: 220, 260 and either 280 or 554 nm. For anal-
ysis purpose, the system was equipped with a Superose 12
10/300 GL column calibrated according to (22). For pu-
rification purpose, it was equipped with an XK 26/100 col-
umn filled with Superose 12 prep grade. Pre-equilibration
of the columns was performed with either chromatogra-
phy or phosphate buffer. The elution flow rate was set at
0.5 ml/min. Peak characteristics (elution volume, area and
width at half-height) were determined using the Unicorn
software.
For SEC characterization of the purified OligAPol, stock
solutions of ODN (5 g/l, i.e. ∼0.76 mM), OligAPol (98 g/l)
and A8–35 (116 g/l, i.e.∼27 mM) were prepared in mQwa-
ter and separately diluted (by 10× for the ODN and by 20×
for the two APols) in chromatography buffer prior to injec-
tion onto the Superose 12 10/300 GL column.
NMR and optical spectroscopy analyses, imaging. 1H and
13C NMR spectroscopy of A8–35 was performed on a
Bruker Avance 400-MHz NMR spectrometer at RT in
perdeuterated methanol (CD3OD), as previously described
(13). 1H NMR spectroscopy of OligAPol and ODN was
realized in a mixture of perdeuterated methanol (CD3OD)
and water (D2O). Examining the chemical composition of
the purified OligAPol by 1HNMR spectroscopy was poorly
informative, because most of the ODN signals overlap with
those of A8–35 (not shown). Aromatic protons (7–9 ppm)
were only weakly detected and their signal could not be
integrated with acceptable accuracy. As regards the octy-
lamine and isopropylamine grafting ratios, however, they
cannot have been affected, considering the OligAPol syn-
thesis strategy, and are necessarily the same for one given
OligAPol and its A8–35 precursor.
Optical spectroscopy measurements were carried out on
an HP-8453 UV-VIS spectrometer (Agilent Technologies).
Imaging of Au NPs was performed using a Leica
DM5500 B upright wide-field microscope equipped with
epifluorescence optics and a ×63 water immersion objec-
tive. Images were recorded using the following settings of
the excitation and emission filters: (i) excitation 470/40
nm––central wavelength and band-width of the filter, emis-
sion 525/50 nm for the anti-bacteriorhodopsin (BR) anti-
body labeled with Alexa Fluor 488; (ii) excitation 531/40
nm, emission 593/40 nm for the ODN labeled with a
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Table 1. ODNs used in the present work, with their sequence, their mass, the backbone type and, if applicable, the type(s) of functionalization used
Name Sequence
Mass
(Da) Backbone Functionalization
ODN 5′ TCC ATG ACG TTC CTG A’CG TT 3′ 6559.3 PS C6-amino linker in 3′
cODN 3′ AGG TAC TGC AAG GAC TCG 5′ 6016.8 PS C6-amino linker in 3′
PS thiol in 3′
polyC 5′ CCC CCC CCC CCC CCC CCC 3′ 5339.3 PS thiol in 3′
polyT 5′ TTT TTT TTT TTT 3′ 3588.4 PO None
ODN stands for the CpG-1826 ODN, cODN for its complementary sequence, polyC for polycytosine and polyT for polythymine. The backbone bond
linking the nucleotides can be either a phosphorothioate (PS) or a phosphodiester (PO) function.
Cy3 dye; (iii) excitation 620/60 nm, emission 700/75 nm
for FAPolAF647 and anti-tOmpA labeled with Alexa Fluor
647. All fluorescence microscopy images presented here are
false-color images.
Purple membrane purification and preparation of BR/APol
complexes. Purple membrane (PM) purification was car-
ried out as described in (15). PM in phosphate buffer at a
BR concentration close to 6 g/l was solubilized with 100-
mM OTG (cmc ≈ 9 mM) for 40 h in the dark at 6◦C and
ultracentrifuged at 200 000 × g for 20 min at 6◦C in a TL
100 ultracentrifuge (Beckman Coulter). The supernatant
was diluted from 100-mM to 18-mM OTG with phosphate
buffer. The concentration of solubilized BR was calculated
from its absorbance at 554 nm using 554 = 43 000 M−1
cm−1.
The protocol for the preparation of BR/APol complexes
was adapted from (15). It comprises the following steps : (i)
formation of a ternary BR/OTG/APol complex by adding
aliquots of a 100-g/l APol stock solution to 300l of solubi-
lized BR; the final BR/APol mass ratio was varied from 1:2
to 1:10; (ii) 20-min incubation on a rotating wheel at 4◦C in
the dark; (iii) removal of the detergent by adsorption onto
polystyrene beads (Bio-Beads SM-2) at a 10:1 beads/OTG
mass ratio, during overnight (ON) incubation on a wheel at
4◦C in the dark; (iv) ultracentrifugation at 100 000 × g at
4◦C for 20 min to remove aggregated material. Ultraviolet
(UV)-visible absorption spectra were recorded before and
after ultracentrifugation to quantify the percentage of BR
kept soluble by the APol. Control samples included BR in
18-mM OTG (no APol and no beads added; positive con-
trol) and BR depleted of OTG in the absence of APol (neg-
ative control).
Purification of tOmpA and preparation of tOmpA/APol
complexes. The transmembrane domain of outer mem-
brane protein A from Escherichia coli (tOmpA) was pro-
duced as described in (23). Briefly, tOmpA was overex-
pressed in E. coli BL21(DE3). After cell lysis, inclusion
bodies were harvested by centrifugation at 4300 × g and
washed with 2% Triton X-100 before being solubilized in
20-mM Tris/HCl, pH 8.0, 8-M urea. Refolding was car-
ried out by dialysis in the presence of tetraethylene glycol
monooctyl ether (C8E4) and the protein purified by ion ex-
change chromatography on a 5-ml HiTrap Q HP column
(GE Healthcare) connected to an A¨kta Purifier device. The
equilibration buffer was 20-mM Tris/HCl, pH 8.0, 19.6-
mM C8E4. The elution buffer contained, in addition, 1-M
NaCl. The protocol for the preparation of tOmpA/APol
complexes was similar to that of BR/APol complexes, but
for the MP/A8–35 w/w ratio, which was 1:4 (3).
cODN grafting onto magnetic beads. The protocol was
adapted from that given by Bioclone. Two-milligram
aliquots of aldehyde-activated magnetic beads were rehy-
drated, washed three times with 500 l of coupling buffer
and supplemented with a solution of functionalized cODN
(75 l of cODN at 2 g/l diluted with 275 l of coupling
buffer) plus 10 l of NaCNBH3 (250 mM in 1-M NaOH,
prepared extemporaneously in a chemistry fume hood due
to its toxicity). After ON incubation on a wheel at RT, the
coupling efficiency was estimated from the cODN concen-
tration remaining in the supernatant, determined by UV
spectrophotometry. Beads were then washed three times
with 500 l of washing buffer. Non-specific interactions
were blocked by ON incubation at RT on a wheel in a solu-
tion of polythymine (25l of polyT at 2 g/l diluted with 275
l of hybridization buffer). Beads were washed three times
with 500 l of hybridization buffer before use.
Immobilization onto cODN-grafted magnetic beads. Two
milligrams of beads in 275-l hybridization buffer were sup-
plemented with either (i) 25 l of 2-g/l ODN solution, (ii)
25 l of 2-g/l polyT solution, (iii) 25 l of 10-g/l A8–35
solution or (iv) 25 l of 10-g/l OligAPol solution. After
20-min incubation at RT on a rotating wheel, supernatants
were separated from the beads using a magnet and ana-
lyzed by UV-visible spectrometry and SEC. For immobiliz-
ing BR/OligAPol complexes, the protocol was modified as
follows: 100 l of complexes formed at 1:7.5 BR/OligAPol
mass ratio (in trapping buffer) were diluted with 100-l mQ
water. The final concentrations of BR and OligAPol were,
respectively, 0.178 and 1.336 g/l. The solution was incu-
bated with 2mg of cODN-grafted beads on a rotating wheel
in the dark at 4◦C for 2 × ∼15 h at 4◦C, with a renewal of
the beads at mid-time. It is notable that equilibrium deple-
tion was reached more slowly with the BR/OligAPol com-
plexes than with the other samples, and it required the addi-
tion of more beads. It seems probable that, because of their
larger size and the lower temperature, MP/OligAPol com-
plexes diffuse more slowly into the beads and do not have
access to the same proportion of bead-attached cODN as
free ODN or OligAPol particles do.
Immobilization of BR trapped in OligAPol onto AuNPs. In
order to directly visualize the anchoring of BR trapped in
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OligAPol onto gold surfaces, 100-nmdiameterAuNPswere
deposited onto glass cover-slips modified as follows. The
glass surface was cleaned for 10 s with acetone, methanol
and ethanol and with plasma etching for 200 s. The glass
slide was then placed on a flat and clean surface and im-
mersed successively in 50 ml of ethanol, 40-l concentrated
HCl (37.2%, 12.1M), 100-l PEG silane and 100l of 1-g/l
PLL solution for 60 min (the PLL solution was sonicated
for 15 min prior to incubation). The glass slide was washed
with ethanol and deionized water for 10 s, then incubated
for 30 min at 75◦C. The slide surface was covered with a
20-l solution of Au NPs (diluted in deionized H2O to a fi-
nal concentration of 3.8 × 108 particles per ml) for 30 min.
The slide was then rinsed for 10 s with a stream of deionized
H2O and dried for 60 s under a gentle stream of N2.
After deposition of AuNPs, the glass slide was incubated
for 1 h with 100 l of 2-M cODN, functionalized with a
thiol tag, diluted in 10-mM Tris pH 8.0, 1-mM EDTA (TE
buffer) and washed for 10 s with TE buffer. In order to as-
sess the accessibility of the cODN on the Au NP surface,
the glass slide was incubated for 2 h with 100 l of 1-M
ODN functionalized with a Cy3 fluorescent tag. In order
to investigate the immobilization of MPs onto modified Au
NPs, it was incubated for 2 h with 100 l of 1-M BR or
tOmpA trapped in a 1:1 OligAPol/FAPolAF647 mixture. Be-
fore imaging, the glass surface was incubated for 10 min in
PPB-T20 with shaking and washed three times with 10-ml
PPB in order to remove non-specifically bound proteins.
In order to demonstrate the presence of the MPs at the
surface of the Au NPs, NPs functionalized with the thio-
lated cODN were first incubated for 2 h either with 1-M
BR trapped in a 1:1 OligAPol/FAPolAF647 mixture or with
1-M tOmpA trapped in a 1:1 OligAPol/A8–35 mixture,
and then incubated for 1 h with 20 nM of a BR-specific an-
tibody labeled with Alexa Fluor 488 or a tOmpA-specific
antibody labeled with Alexa Fluor 647, respectively. NPs
were then incubated with PPB-T20 for 10 min to wash off
any non-specifically bound antibody and imaged.
Two different control experiments were designed to con-
firm the specificity of the interaction between Au NPs func-
tionalized with cODN and OligAPol-trapped MPs: (i) Au
NPs were incubated first for 2 h with 100 l of 1-M thi-
olated polycytosine DNA strands, which are not comple-
mentary to the ODN, and then with 1-M BR trapped in
OligAPol/FAPolAF647; (ii) Au NPs functionalized with the
cODN were incubated first for 2 h with 2-M ODN la-
beled with a Cy3 dye and then for 2 h with BR trapped
in OligAPol/FAPolAF647. In both experiments, the samples
were finally incubated for 10 min with PPB-T20 in order to
remove any non-specifically bound protein.
The reversibility of the hybridization of the OligAPol to
the cODN was investigated by first functionalizing Au NPs
with cODN and BR trapped in OligAPol/FAPolAF647, and
then incubating the sample either with 8-M urea for 10 min
under shaking or at 72◦C in PPB for 10 min. The samples
were then washed for 10 min with PPB-T20 and imaged in
PPB.
RESULTS
Synthesis of OligAPol
Coupling reaction. OligAPol was obtained by forming an
amide bond between an aminated ODN and one of the ac-
tivated carboxylate functions of A8–35. The reaction was
carried out in aqueous medium because of the low solubil-
ity of the ODN into organic solvent. This route has been
used previously for the synthesis of sulfonated APols (24).
Given that MP/A8–35 complexes typically comprise ≥40-
kDa APol per complex [reviewed in (2)], i.e. at least the
equivalent of one A8–35 particle (10), a grafting level of at
least one ODN per particle was aimed for, so as to ensure a
nearly quantitative immobilization of any target MP.
Grafting is carried out in aqueous solution, i.e. on already
assembled A8–35 particles. The synthesis protocol involves,
first, the activation of free carboxylate groups of A8–35 by
converting a fraction of them, in the presence of EDC and
NHS, into a reactive NHS ester. The second step is the re-
action of the ODN derivative with the activated ester func-
tion (Scheme 1). As observed in earlier works (25,26), deter-
mining optimum experimental conditions called for carry-
ing out numerous preliminary tests in different aqueous and
dimethylformamide (DMF)/H2O buffers, at various ionic
strengths (0.1–0.4 M NaCl), and for various ODN/A8–35
ratios and crosslinker concentrations (see theMaterials and
Methods section).
Monitoring OligAPol synthesis by SEC. A8–35 particles
and the ODN used here have quite different masses (∼40
and 6.6 kDa, respectively) and different spectroscopic prop-
erties [ODNs absorb maximally at 260 nm, whereas A8–35
is detected at 220 nm and does not absorb significantly at
260 nm; (3)]. SEC coupled with detection at multiple wave-
lengths is therefore an efficient way of following the conju-
gation reaction. Figure 1 shows the evolution of the chro-
matograms observed at 220 and 260 nm between the begin-
ning of a synthesis, at t= 0 [i.e. before addition of EDC and
NHS; panel (A)], and its end, at t = 48 h [panel (B)]. At t =
0, two peaks are observed. Peak , eluting at∼13.8 ml and
absorbing both at 220 and 260 nm, corresponds to the free
ODN, peak , eluting at∼12 ml and absorbing only at 220
nm, to A8–35 particles. After the reaction [panel (B)], the
surface of the ODN peak decreases, while the A8–35 peak
shifts to a lower elution volume (11.3 ml; peak ), with
the appearance of an absorbance at 260 nm and an increase
of that at 220 nm, reflecting the grafting of the ODN. NHS
elutes at ∼17.5 ml [peak , panels (B) and (C)], traces of
EDC at ∼19 ml. OligAPol particles thus migrate as though
they are significantly larger than those of ungrafted A8–35,
and they seem more polydisperse. The decrease of the free
ODN peak ( ) at 260 nm provides an estimate of the evo-
lution of the reaction, well correlated (within ±20%) with
the increase of the OligAPol one ( ).
OligAPol purification. A two-step purification process
was used to remove by-products and unreacted materials.
Whereas free ODN remains water-soluble until pH ≈ 2–3,
A8–35 forms aggregates at pH < 7 and precipitates at pH
< 5 (10,13). The first purification step therefore comprised
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Figure 1. Monitoring of the coupling of ODN to A8–35 by size exclusion
chromatography. Elution profiles at 220 nm and 260 nm of the reaction
medium before [panel (A), t= 0] and 48 h after addition of EDC and NHS
[panel (B)]. Initial concentrations were 13.2-g/l A8–35, 4.8-g/l ODN, 25.5-
g/l EDC, 4.7-g/l NHS and 0.4-M NaCl. Panel (C) illustrates the elution
of a 9-g/l NHS solution. Peaks are numbered as follows: , free ODN;
, A8–35 particles; , OligAPol particles; NHS.Vel, elution volume;
V0, excluded volume; VT, total volume.
Figure 2. SEC analysis of purified OligAPol. Elution profiles at 220 nm
(top) and 260 nm (bottom) of purified OligAPol and its precursors, A8–35
and ODN. The concentrations injected were ∼4.9-g/l OligAPol, ∼5.8-g/l
A8–35 (∼1.35 mM) and ∼0.5-g/l (∼0.076 mM) ODN. The profiles were
normalized to the same maximum. a.u.: arbitrary units. Vel, elution vol-
ume; V0, excluded volume; VT, total volume.
a selective precipitation at pH 3.25. Purification was incom-
plete, and most of the residual free ODN was removed by
preparative SEC (see the Materials and Methods section).
For SEC characterization of the final product, stock solu-
tions ofODN,OligAPol andA8–35were injected onto a Su-
perose 12 10/300 GL column (see the Materials and Meth-
ods section). Elution profiles with the absorbance at 220 and
260 nm normalized to the samemaximum are shown in Fig-
ure 2. The peak of purified OligApol is characterized by a
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lower elution volume (Vel = 11.3 versus 12.0ml) and a larger
width at half height (WHH = 1.8 versus 1.1 ml at 220 nm)
than that of the precursor A8–35 (Figure 2, top). It appears
narrower at 260 nm (WHH = 1.5 ml), because ungrafted
A8–35 does not absorb at this wavelength (Figure 2, bot-
tom). A small fraction of residual free ODN is detected at
∼14 ml (see below).
Quantification of ODN grafting ratio in OligAPol. The
grafting ratio was determined as follows. First, the total
mass of ODN present in purified OligAPol samples, mODN,
was determined, using a calibration curve for free ODN,
from the absorbance at 260 nm. Second, SEC analysis (Fig-
ure 2) established that residual ungrafted ODN represents
∼10% of this total. Third, the mass of A8–35, mA8–35, was
calculated by subtracting mODN from the total mass of the
purified OligAPol sample, determined by weighing. The
mass ratio of grafted ODN to A8–35 was then calculated
as (mODN × 0.9)/mA8–35. Under optimal conditions, this
yielded a ratio of 0.078 g ODN per g A8–35. Given the
molecular mass of the ODN (6.56 kDa), this corresponds
to ∼0.47 grafted ODN per 40-kDa A8–35 particle. Purified
OligAPol therefore consists of an ∼1:1 mixture of grafted
and ungrafted APol particles. The desirable objective of one
ODN per particle appears out of reach using the present
synthesis procedure (see the Materials and Methods sec-
tion).
MP trapping: comparison between A8–35 and OligAPol
MP trapping by OligAPol was tested using BR as a
model protein. PM was purified from Halobacterium sali-
narum, solubilized in OTG, and BR was transferred to
APols as described in (15,27). Parallel trapping experiments
were carried out using OligAPol and its parent A8–35, at
protein/APol mass ratios varying from 1:2 to 1:10. After
adsorption of OTG onto Bio-Beads and centrifugation, vi-
sual observation of the different samples showed that: (i)
BR precipitated when OTG was removed in the absence
of APol (negative control); (ii) a pellet was observed at
BR/OligAPol mass ratios of 1:2 (important) and 1:5 (neg-
ligible); (iii) all of BR remained in the supernatant for the
positive control (no removal ofOTG, noAPol), for BR/A8–
35 samples atmass ratios 1:5 and 1:10 and for BR/OligAPol
samples at mass ratios 1:7.5 and 1:10 (Figure 3, top). These
results were confirmed by the UV-visible absorbance spec-
tra of the supernatants, which showed the presence of native
BR with a visible absorption peak at 554 nm (Figure 3, bot-
tom), indicating that OligAPol keeps BR in its native state
[upon denaturation, BR releases its cofactor, retinal, which
absorbs at ∼380 nm, as visible in the spectrum of sodium
dodecyl sulphate (SDS)-denatured PM]. The percentage of
BR kept soluble was calculated from the absorbance at 554
nm before and after ultracentrifugation (Figure 3, top). In
the absence of surfactant, BR precipitated nearly quanti-
tatively, whereas in the presence of OTG it remained solu-
ble, a slight release of retinal––due to the lesser stability of
BR in detergent solution––being responsible for the small
peak observed at∼380 nm (Figure 3, bottom). At the lowest
BR/OligAPol ratio used (1:2 w/w), ∼70% of BR remained
Figure 3. OligAPol keeps BR soluble and native. (Top) Percentage of BR
present in the supernatant after trapping at BR/OligAPolmass ratios vary-
ing from 1:2 to 1:10. Absorbance at 554 nm was taken as a measurement
of the concentration of native BR. Control samples included BR trapped
in A8–35 at 1:5 and 1:10 mass ratios, BR kept in 18-mM OTG (positive
control) and BR depleted from OTG in the absence of APol (negative con-
trol). Error bars correspond to the standard deviation on ≥3 experiments.
(Bottom) To three identical samples of BR in OTG solution were added
either OligAPol (©), or plain A8–35 (∇), both in a 1:5 BR/APol mass ra-
tio, or no APol at all (	). All samples were then depleted from OTG with
Bio-Beads, except for the positive control (). After overnight incubation
at 4◦C, the beads were removed and the samples centrifuged at 100 000 ×
g for 20 min at 4◦C before recording UV-visible absorbance spectra. The
spectrum of SDS-solubilized purple membrane (solid line) shows the peak
of absorbance at ∼380 nm of free retinal released upon BR denaturation.
Vel, elution volume; V0, excluded volume; VT, total volume.
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Figure 4. Size exclusion chromatography analysis of BR/OligAPol com-
plexes and comparison with BR/A8–35 complexes. (Top) Chromato-
graphic profiles at 554 nm of four BR samples trapped with OligAPol at
BR/OligAPol mass ratios varying from 1:2 to 1:10. (Bottom) Chromato-
graphic profiles at 554 nm of a sample of BR trapped at a BR/OligAPol
mass ratio of 1:7.5 and a sample trapped in A8–35 at a BR/A8–35 mass
ratio of 1:5. Vel, elution volume; V0, excluded volume; VT, total volume.
in the supernatant; at all other ratios, the protein was com-
pletely soluble.
Supernatants were analyzed by SEC to estimate the size
distribution of BR/OligAPol complexes. Figure 4 (top)
shows the elution profiles at 554 nm for BR/OligAPol mass
ratios varying from 1:2 to 1:10. At ratio 1:2, an important
fraction of the protein was aggregated and eluted in the void
volume V0 of the column. At ratio 1:5, this fraction was
much reduced. At ratios 1:7.5 and 1:10 (Figure 4, top), no
aggregates were present and a well-defined peak of soluble
BR was observed. BR/OligAPol complexes elute at Ve ≈
10.4 ml, as compared to 11.3 ml for pure OligAPol parti-
cles. Their apparent size is significantly larger than that of
BR/A8–35 ones, which elute atVe ≈ 10.8 ml (Figure 4, bot-
tom). The BR/OligAPol peak is also broader, with a WHH
increase from 0.6 ml to 1.2 ml, reflecting the fact that some
complexes carry one or more grafted ODN(s) while others
do not. The ability of A8–35 to trap and keep soluble BR,
however, does not appear to be significantly affected by the
presence of the ODN.
Accessibility of the ODN tag to hybridization with a cODN
A2-g/l OligAPol solution was supplemented with cODNat
0.25 g/l final concentration, corresponding to a 1:1.6 molar
ratio of ODN to cODN. The chromatograms at λ = 220
nm of the OligAPol sample and the OligAPol + cODN one
are shown in Figure 5 (top). As observed before (Figure 2),
the OligAPol sample migrates as two peaks, a minor peak
of free ODN at Ve = 14.0 ml (labeled in the figure) and
a major, broad peak at 11.3 ml, comprising a mixture of
ODN-carrying and ODN-free A8–35 particles ( ). The
chromatogram of the mixture of OligAPol and cODN fea-
tures four peaks: : a large peak at 14.1 ml, corresponding
to the excess of cODN; : a small peak at 12.9 ml, due to
the formation of the free ODN/cODN duplex; : a peak
of ODN-free A8–35 particles at ∼11.7 ml (this peak indeed
does not appear at λ = 260 nm; not shown); : a large
peak at 10.6 ml, representing the hybrid OligAPol/cODN.
Because hybridization increases the RS of this last fraction
as compared to that of pure OligAPol, it becomes more dis-
tinct from untagged A8–35 ( ) than OligAPol is in the ab-
sence of cODN (cf. Figure 2, top).
Next, cODN was added to BR/OligAPol complexes
trapped at a mass ratio of 1:7.5 (final concentrations:
0.4-g/l BR, 3-g/l OligAPol and 0.37-g/l cODN, corre-
sponding to molar ratios of ∼2.2 ODNs per BR and
1.6 cODNs per ODN). At λ = 554 nm (Figure 5, bot-
tom), the peak of BR/OligAPol complexes is seen to elute
slightly earlier in the presence than in the absence of cODN,
Ve shifting from 10.4 to 10.0 ml. The distribution be-
comes more markedly asymmetrical, because the RS of the
BR/OligAPol/cODN complexes increases with respect to
that of the BR/OligAPol ones, while that of the BR/A8–
35 complexes does not change. As a result, WHH increases
from 1.2 to 1.55 ml.
In summary, SEC analyses indicate that the ODN tag is
accessible and free to hybridize with a cODN whether the
OligAPol exists as free particles or is bound to an MP.
Immobilization of OligAPol-trapped MPs onto magnetic
beads carrying a cODN
cODN-coated magnetic beads prepared by reductive ami-
nation (see the Materials and Methods section) were used
to immobilize BR/OligAPol complexes. The beads were in-
cubated with five types of samples (Figure 6): (i) polyT,
an ODN with a base sequence non-complementary to the
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Figure 5. Accessibility of the ODN tag to hybridization with a cODN.
(Top) Accessibility in OligAPol particles. Chromatograms at 220 nm of an
OligAPol sample before (©) and after (∇) supplementation with cODN.
free ODN; OligAPol particles; free cODN; ODN/cODN
duplex; ODN-free A8–35 particles; OligAPol particles hybridized
with cODN. (Bottom) Accessibility in BR/OligAPol complexes. BR was
trapped at a 1:7.5 BR/OligAPol mass ratio and supplemented (∇) or not
(©) with cODN. A554 absorbances were normalized to the same maxi-
mum. a.u.: arbitrary units. Vel, elution volume; V0, excluded volume; VT,
total volume. The broadening of the peak of BR and its asymmetrical
shape after addition of cODN reflect the fact that only approximately two-
third of the BR/OligAPol complexes actually carry an ODN tag.
cODN; (ii) the ODN used to functionalize A8–35; (iii) un-
functionalized A8–35; (iv) free OligAPol particles; and (v)
BR/OligAPol complexes. The degree of binding of each lig-
and to the beads was assessed bymeasuring the depletion of
Figure 6. Quantitative analysis of the binding of ODN and OligAPol
onto cODN-grafted magnetic beads. cODN-grafted beads (2 mg) were
mixed with either polyT (0.05 mg), ODN (0.05 mg), A8–35 (0.25 mg),
OligAPol (0.25 mg) or BR/OligAPol complexes (0.036-mg BR and 0.27-
mg OligAPol). All samples except the BR/OligAPol one were incubated
for 20 min at RT on a rotating wheel. To reach maximal adsorption, the
BR/OligAPol sample had to be incubated for 2 × ∼15 h at 4◦C, with a
renewal of the beads at mid-time (see text). The supernatants were sub-
jected to SEC and the surface of the relevant peaks determined at 220, 260
and/or 554 nm. It is given as a percentage of that measured for an aliquot
analyzed before the addition of the beads.
the sample by SEC. Very little interaction was observed in
cases (i) and (iii), with more than 80% of the analyte (polyT
or A8–35) remaining in the supernatant. On the contrary,
free ODN (<10% of which remained in the supernatant),
OligAPol and BR/OligAPol complexes hybridized specif-
ically (Figure 6). In the case of pure OligAPol, <10% of
the initial material was detected in the supernatant at 260
nm versus ∼50% detected at 220 nm. This result was ex-
pected, given that OligAPol is an ∼1:1 mixture of grafted
and ungrafted A8–35 particles. Free ungrafted A8–35 par-
ticles, which absorb at 220 nm and virtually not at 260 nm,
mostly remained in the supernatant, as observed for plain
A8–35 [sample (iii)]. In the case of BR/OligAPol complexes,
the absorbance of the sample dropped by >60% at 220 nm,
a wavelength at which BR, the APol and the ODN all con-
tribute, by ∼90% at 260 nm, at which A8–35 essentially
does not absorb, and by ∼70% at 554 nm, where only na-
tive BR absorbs. These figures are consistent with expec-
tations. BR has been shown to bind ∼54 kDa of A8–35
per BR monomer (15). Given that the ODN grafting ratio
in OligAPol is ∼0.47 tag per 40 kDa, approximately two-
third of the BR can be expected to actually carry at least
one ODN tag, the rest being complexed by untagged A8–
35. This is roughly consistent with the ∼25% of BR that
remain in the supernatant. On the contrary, nearly all of
the ODN, whether free, bound to free OligAPol particles, or
attached to BR/APol complexes, adsorbs onto the cODN-
carrying beads. Presumably due to the lower temperature
(4◦C) and their larger size, MP/OligAPol complexes how-
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ever adsorbed more slowly than OligAPol particles or free
ODN, and reaching maximal adsorption required the addi-
tion ofmore beads (see theMaterials andMethods section).
OligAPol-mediated immobilization of MPs onto gold sur-
faces
Au NPs immobilized onto PLL-modified glass slides were
used to (i) explore the possibility of using OligAPol
for anchoring MPs onto gold surfaces and (ii) directly
observe, by fluorescence microscopy, the hybridization
of MP/OligAPol complexes and cODN onto solid sup-
ports and the binding of antibodies to immobilized MPs.
The strong electrostatic interaction between the positively
charged PLL and the negatively charged surface of Au NPs
ensured a stable immobilization. Differential interference
contrast (DIC) images (Figure 7A) showed well-dispersed
particles. After incubation first with cODN carrying a thiol
tag, and then with ODN labeled with a Cy3 fluorescent
tag, imaging showed co-localization of the DIC and fluo-
rescence signals, indicating that Au-bound cODN retains its
ability to hybridize to the ODN present in the soluble phase
(Supplementary Figure S1).
To observe single beads carrying immobilized MPs, BR
was trapped in a 1:1 mixture of OligAPol and Alexa
Fluor 647-labeled A8–35 [FAPolAF647; see (21)]. After in-
cubation with these complexes, cODN-functionalized Au
NPs exhibited a strong and homogeneous fluorescence sig-
nal (Figure 7B). Single-particle analysis of the fluores-
cence images showed a ratio between the average signal
recorded on Au NPs and the background of ∼10 (Fig-
ure 7G), indicative of a low level of non-specific bind-
ing of the mixed BR/OligAPol/FAPolAF647 complexes and
free OligAPol/FAPolAF647 particles to the PEG silane layer.
Similar results were obtained upon incubation of cODN-
functionalized beads with another MP, tOmpA, trapped
with the same 1:1 OligAPol/FAPolAF647 mixture (Supple-
mentary Figure S2). The presence of the MPs onto Au
NPs was confirmed by incubation with Alexa Fluor 488-
or Alexa Fluor 647-labeled antibodies (16) directed against
BR (Figure 7C) or against tOmpA (Supplementary Figure
S3). Thus both BR and tOmpA, once anchored onto Au
NPs via the OligAPol, retain their ability to recognize spe-
cific ligands.
Two different control experiments were designed to con-
firm the specificity of the interaction between cODN-coated
Au NPs and OligAPol-trapped MPs. No binding was ob-
served when Au NPs were coated with thiolated poly-
cytosine, which is not complementary to the ODN (Figure
7E), nor onto cODN-coated Au NPs that had been pre-
incubated with a free, Cy3-labeled ODN (Figure 7F), hy-
bridization of the free ODN being confirmed by the fluo-
rescence signal (Supplementary Figure S4). The specific sig-
nal measured in these control experiments was much lower
(∼10%) and barely emerged from the background noise
(Figure 7G).
Reversibility of MP immobilization
Immobilization of MPs via OligAPols offers the ad-
vantage of being reversible. Supplementary Figure S5A
Figure 7. Immobilization of BR via OligAPol hybridization onto Au
NPs and specific recognition by an anti-BR antibody. (A) DIC image of
Au NPs (100-nm diameter) deposited on a PLL-modified glass slide and
washed with 10-mM potassium phosphate buffer, pH 7.2 (PPB). (B) Fluo-
rescence image of Au NPs preincubated with cODN, washed with PPB,
and incubated for 2 h with BR trapped in a 1:1 OligAPol/FAPolAF647
mixture. (C) and (D) Fluorescence images of Au NPs preincubated with
cODN, washed with PPB and incubated, for 2 h, either with BR trapped
in a 1:1 OligAPol/FAPolAF647 mixture (C) or, as a control, with the
OligAPol/FAPolAF647 mixture alone (D), after which both samples were
washedwith PPB and incubated for 1 hwith a BR-specific antibody labeled
with Alexa Fluor 488. The fluorescence image showed a much smaller sig-
nal when BR/OligAPol/FAPolAF647 complexes were incubated with par-
ticles coated with non-complementary poly-C DNA strands (E) or with
Au NPs functionalized with the cODN, but hybridized with an excess of
Cy3-labeled ODN prior to the addition of the BR/OligAPol/FAPolAF647
complexes (F). Brightness and contrast settings are the same for each set
of images (B, E, F and C, D, respectively). Scale bar is 5 m. (G) Line
scans extracted from panels (B), (E) and (F). Each scan went through two
representative NPs.
shows an image of Au NPs that were first functionalized
with cODN and BR trapped in OligAPol/FAPolAF647,
and then exposed to urea. The fluorescence image
(signal/background ≈ 3) indicates that most of the com-
plexes have been released from the Au surface. Similar
results were obtained when cODN-coated Au NPs with
bound BR/OligAPol/FAPolAF647 complexes were incu-
bated above the estimated melting temperature of the
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Figure 8. Average fluorescence signals measured on AuNPs following var-
ious treatments. 1. Basic control for functionalization of Au NPs with
the cODN: hybridization with an ODN labeled with a Cy3 dye. 2. Im-
mobilization onto cODN-coated NPs of BR/OligAPol/FAPolAF647 com-
plexes. 3. Control 1: Au NPs functionalized with poly-C, incubation with
BR/OligAPol/FAPolAF647 complexes. 4. Control 2: Au NPs functional-
ized with cODN and hybridized with an ODN labeled with a Cy3 dye be-
fore incubation with BR/OligAPol/FAPolAF647 complexes. 5. Control 3:
incubation of cODN-coated NPs with BR/A8–35/FAPolAF647 complexes.
6. Dehybridization 1: incubation with 8-M urea of Au NPs with bound
BR/OligAPol/FAPolAF647 complexes. 7.Dehybridization 2: incubation at
72◦C for 10 min of Au NPs with bound BR/OligAPol/FAPolAF647 com-
plexes. 8. Re-binding of BR/OligAPol/FAPolAF647 complexes to Au NPs
that had been dehybridized for 10 min at 72◦C.
duplex (Supplementary Figure S5B). The low residual
fluorescence signal indicates that most of the BR/APol
complexes have been released from the surface. cODN-
coated Au NPs recover at least part of their binding
capacity after the melting step: Au NPs re-incubated with
BR/OligAPol/FAPolAF647 complexes showed a homoge-
neous fluorescence signal, demonstrating that complexes
had bound again (Supplementary Figure S5C and D).
Quantitative fluorescence measurements on Au NPs un-
der various conditions are summarized in Figure 8.
DISCUSSION
Synthesis of OligAPol
Under the present synthesis conditions, the grafting ratio
of ODN to A8–35 approaches ∼0.5 ODN per APol par-
ticle, which is less than what was aimed for but sufficient
for the applications envisioned. Achieving higher degrees of
tagging would require either a different grafting protocol or
subsequent enrichment. The final preparation retains∼10%
of unbound ODN. This, however, has only a marginal im-
pact on MP immobilization.
Solution properties of OligAPol
A8–35 molecules (on average ∼4.3 kDa) grafted with the
ODN (6.6 kDa) assemble with ungrafted molecules to form
A8–35-like particles, indicating that the behavior of the
polymer is not severely perturbed by the presence of the
large hydrophilic tag. The hydrodynamic radii of OligAPol
particles, A8–35 particles and free ODN are, respectively,
∼4.1 nm, ∼3.4 nm and ∼2.1 nm (Figure 2). Most function-
alized APols synthesized previously carried relatively small
functional groups (5). Whenever examined, the size of APol
particles was not affected, be it by the presence of NBD (7-
nitrobenz-2-oxa-1,3-diazol-4-yle) (3), rhodamine (9), fluo-
rescein (28) or biotin (unpublished data). Here, the ODN
tag is big enough to detectably increase the RS of OligAPol
particles as compared to that of plain A8–35. This effect
cannot be due to the increase in particle mass, which is neg-
ligible [∼47 kDa with one ODN bound versus ∼40 kDa for
untagged particles (10)]. It suggests that the ODN extends
away from the surface of the APol particle, possibly due to
electrostatic repulsion. Nevertheless, the binding of such a
large hydrophilic tag prevents neither the assembly of the
polymer into well-behaved particles nor its use to trapMPs.
This holds true, at least, for the present level of grafting.
MP trapping and hybridization
The ability of OligAPol to trap BR is similar to that
observed for the precursor A8–35, but a slighter higher
APol/protein mass ratio is required to ensure complete dis-
persion of BR into monomers. Considering that the parti-
cles are only ∼8% more massive than those of plain A8–
35 (on average ∼43.3 versus ∼40 kDa), one might have ex-
pected a negligible impact. Steric hindrance and repulsive
interactions between ODN and A8–35 molecules may af-
fect trapping efficiency. Yet, there is probably no redistribu-
tion of ODN-carrying molecules toward protein-free par-
ticles: indeed, the yield of immobilization of BR/OligAPol
complexes onto cODN-bearing beads is consistent with a
random distribution of grafted APols between free parti-
cles and protein-bound polymers, suggesting that there is
no exclusion of the grafted polymers from the surface of
the protein.
Immobilization of OligAPol-trapped MPs
OligAPol-mediated immobilization of MPs was demon-
strated using two different MPs (BR and tOmpA), two dif-
ferent solid supports (magnetic beads and Au NPs), two
methods for binding the cODN to the support (formation of
a covalent bond or chemisorption) and two analytical tech-
niques (spectroscopy and fluorescence microscopy), the en-
semble of which provides complementary information on
the yield of immobilization, its homogeneity, its reversibil-
ity and the generality of the approach.
Immobilization of free ODN and free OligAPol parti-
cles onto cODN-coated magnetic beads occurred rapidly
(within 20 min at RT). The process was slower for
BR/OligAPol complexes, requiring 2× ∼15 h (at 4◦C), with
a renewal of the beads at mid-time in order to reach maxi-
mal adsorption. This is probably due to slower diffusion at
4◦C and a limited accessibility to the bead-bound cODN of
the relatively large BR/OligAPol complexes (∼95 kDa).
Fluorescence microscopy observation of the adsorption
onto single Au NPs provided a more detailed view of the
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